VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NCELNewcelX Ltd.
$3.79$2M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

NCEL logoNewcelX Ltd.(NCEL)Earnings, Financials & Key Ratios

NCEL•NASDAQ
$3.79
Price updated Jun 27, 2026
  • Revenue$0
  • EBITDA-$4M+62.9%
  • Net Income-$2M+83.7%
  • EPS (Diluted)-26.30-721.9%
  • ROE-140.85%

NCEL Price & Volume

NewcelX Ltd. (NCEL) stock price & volume — 10-year historical chart

Loading chart...

Persistent Revenue Absence Signals Existential Liquidity Risk

Investment Thesis • Updated 2025Q2

VerdictNegative
Growth:Contracting
Profitability:Negative
Financial Position:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent liquidity exhaustion
"NewcelX Ltd. remains a pre-commercial biotechnology entity characterized by a total lack of revenue and a history of significant accumulated deficits totaling $74.8M. The company's reliance on external capital to fund R&D and administrative overhead, coupled with a quarterly operating loss of $1.8M, presents an unsustainable financial trajectory. Investors should exercise extreme caution as the current cash position of $1.66M suggests an imminent need for dilutive financing or a strategic transaction to avoid insolvency."

Verdict Logic

the company's unsustainable burn rate, evidenced by a $1.8M quarterly operating loss against only $1.66M in cash, indicates a high probability of near-term liquidity exhaustion.

NCEL Growth Metrics

NewcelX Ltd. (NCEL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM86.63%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-42.48%

Return on Capital

10 Years-360.56%
5 Years-332.68%
3 Years-322.59%
Last Year-311.45%

Peers Comparison

Key metrics vs top competitors for NewcelX Ltd. (NCEL)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
NCEL logoNCELNewcelX Ltd.Current
$3.79$1.71M-0.14——-140.85%—
GEVO logoGEVOGevo, Inc.
$1.40$340.78M-10.00849.33%-19.38%-7.19%—
LOOP logoLOOPLoop Industries, Inc.
$0.83$40.16M-3.19-95.28%-2392.61%——
BIOX logoBIOXBioceres Crop Solutions Corp.
$0.33$21.16M-0.41-28.3%-82.77%-92.01%—
RGEN logoRGENRepligen Corporation
$147.01$8.29B170.9416.36%6.73%2.46%—
RYAM logoRYAMRayonier Advanced Materials Inc.
$8.00$539.15M-1.27-10.08%-32.82%-147.1%—

Compare NCEL vs Peers

NewcelX Ltd. (NCEL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs GEVO

Most directly comparable listed peer for NCEL.

Scale Benchmark

vs BE

Larger-name benchmark to compare NCEL against a more recognizable public peer.

Peer Set

Compare Top 5

vs GEVO, LOOP, BIOX, RGEN

Get notified when NCEL posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

NCEL Frequently Asked Questions

NewcelX Ltd. (NCEL) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
Is NCEL profitable?

NewcelX Ltd. (NCEL) reported a net loss of $4.2M for fiscal year 2024.

Dividend & Returns
What is NCEL's return on equity?

NewcelX Ltd. (NCEL) has a return on equity (ROE) of -140.8%. Negative ROE indicates the company is unprofitable.

What is NewcelX Ltd.'s free cash flow?

NewcelX Ltd. (NCEL) had negative free cash flow of $6.3M in fiscal year 2024, likely due to heavy capital investments.

What if you invested $1,000 in NCEL back in 2017?

Total return calculator · dividends reinvested · 9+ years of data

See returns →